|
Market Closed -
Australian S.E.
00:55:18 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.7150 AUD | -4.67% |
|
-12.27% | -26.29% |
| 08-28 | OncoSil Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-27 | OncoSil Medical Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 26.24M 18.46M 16.57M 15.3M 13.87M 25.92M 1.75B 183M 72.83M 919M 69.28M 67.8M 2.91B | P/E 2027 * |
-0.02x | P/E 2028 * | -0.04x |
|---|---|---|---|---|---|
| Enterprise Value | 26.24M 18.46M 16.57M 15.3M 13.87M 25.92M 1.75B 183M 72.83M 919M 69.28M 67.8M 2.91B | EV / Sales 2027 * |
4.45x | EV / Sales 2028 * | 2.76x |
| Free-Float |
90.14% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: OncoSil Medical Limited
| 1 day | -4.67% | ||
| 1 week | -12.27% | ||
| Current month | -17.34% | ||
| 1 month | -15.88% | ||
| 3 months | -38.89% | ||
| 6 months | +47.42% | ||
| Current year | -26.29% |
| 1 week | 0.7 |  | 0.8 |
| 1 month | 0.68 | | 0.88 |
| Current year | 0.37 | | 1.64 |
| 1 year | 0.37 | | 1.64 |
| 3 years | 0.37 | | 6 |
| 5 years | 0.37 | | 32.4 |
| 10 years | 0.37 | | 102 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nigel Lange
CEO | Chief Executive Officer | - | 2021-01-20 |
Shelley Steyn
DFI | Director of Finance/CFO | - | 2025-05-04 |
Jon Bell
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Nigel Lange
BRD | Director/Board Member | - | 2021-01-20 |
Lel Smits
BRD | Director/Board Member | - | 2025-01-14 |
Thomas Duthy
CHM | Chairman | - | 2025-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/20/21 | Free | Chief Executive Officer | 2,841,633 | 0.3586% | ||
| 8/24/21 | Buy | Director | 95,000 | 0.0119% | ||
| 5/10/21 | Sell | Chairman | 10,000,000 | 1.2386% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.67% | -12.27% | -52.33% | -80.14% | 19.36M | |
| +0.96% | +2.14% | +58.27% | +129.44% | 1,143B | |
| +1.10% | +5.64% | +45.69% | +85.22% | 647B | |
| +0.48% | +1.27% | +26.76% | +103.28% | 506B | |
| +0.01% | +1.94% | +53.04% | +65.60% | 384B | |
| -0.41% | -5.59% | +62.59% | +37.81% | 350B | |
| +0.84% | +2.63% | +31.71% | +53.87% | 293B | |
| +0.29% | +2.11% | +3.82% | +26.05% | 265B | |
| +1.17% | +3.51% | +55.34% | +72.40% | 242B | |
| +0.74% | +4.42% | +36.04% | +106.20% | 197B | |
| Average | +0.04% | -0.04% | +32.09% | +59.97% | 402.76B | |
| Weighted average by Cap. | +0.65% | +0.71% | +45.39% | +88.13% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 5.9M 4.15M 3.72M 3.44M 3.12M 5.83M 394M 41.23M 16.37M 207M 15.58M 15.24M 655M | 9.5M 6.68M 6M 5.54M 5.02M 9.38M 635M 66.39M 26.37M 333M 25.08M 24.54M 1.05B |
| Net income | -9.6M -6.75M -6.06M -5.6M -5.07M -9.48M -641M -67.09M -26.64M -336M -25.34M -24.8M -1.07B | -5.7M -4.01M -3.6M -3.32M -3.01M -5.63M -381M -39.83M -15.82M -200M -15.05M -14.73M -633M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | A$0.7150 | -4.67% | 23,117 |
| 26-10-27 | A$0.7500 | +7.14% | 14,682 |
| 26-10-26 | A$0.7000 | -2.78% | 22,213 |
| 26-10-23 | A$0.7200 | -8.86% | 56,688 |
| 26-10-22 | A$0.7900 | -1.25% | 13,646 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7150
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSL Stock
Select your edition
All financial news and data tailored to specific country editions
